Concepedia

José A. Karam

JA

Statistics

Publications

167

Citations

12K

H-Index

53

Active since

2004

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Southwestern Medical Center

Baylor College of Medicine

Dana-Farber Cancer Institute

Université de Montréal

José A. Karam is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and kidney cancer.

ORCID

Publications per year

2004–2025

167

Publications

167

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

Daniel R. Gomez, Chad Tang, Jianjun Zhang et al. · Journal of Clinical Oncology · 2019 · 1.3K citations · Full text

, , +15

Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

Daniel R. Gomez, George R. Blumenschein, Mike Hernández et al. · The Lancet Oncology · 2016 · 1.1K citations · Full text

, , +7

Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I

Steven C. Campbell, Peter E. Clark, Sam S. Chang et al. · The Journal of Urology · 2021 · 725 citations

, , +17

Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

Lijun Zhou, Mingli Sun, Xian Zhang et al. · Oncogene · 2015 · 393 citations

, , +12

Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial

Nizar M. Tannir, Eric Jonasch, Laurence Albigès et al. · European Urology · 2015 · 360 citations · Full text

, , +14

1–5 of 167